ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Integrative multi-omics analysis identifies SELL and PRF1 as key immune biomarkers and therapeutic targets in tuberculosis.
Tatyana Tarkina et al.PubMed ↗Publisher ↗
No numbers read from the abstract.